BeWell Buddy is looking for contributors:

Would you like to post an article or write a review? Contact Us Here.

Immutep Announces Positive Interim Results In Phase I/II Chemoimmunotherapy Trial In Breast Cancer

Jan 5th, 2009 | By buddy1 | Category: Health & Wellness News, Pharmaceutical Headlines

Immutep S.A. announced today interim results from its ongoing Phase I/II chemoimmunotherapy clinical trial in metastatic breast carcinoma. ImmuFact IMP321 was administered the day after weekly paclitaxel for six months. The interim results show a clinical response rate of 50 per cent compared to 25 per cent with paclitaxel alone. In addition, a robust immune response was observed in clinically-responding patients.

Read The Full Article...Immutep Announces Positive Interim Results In Phase I/II Chemoimmunotherapy Trial In Breast Cancer
$5 VITAMIN SALE!! Plus get FREE SHIPPING on any order over $25. No coupon needed. Hurry, sale ends soon!
  • Share/Save/Bookmark
No tags for this post.

Related posts

Leave Comment

You can add images to your comment by clicking here.